Back to today’s briefing

Story perspectives

FDA Vaccine Chief Resigns Amid Controversial Gene Therapy Management

7/31/2025

44 9

Summary

Story summary

Dr. Vinay Prasad has stepped down as the FDA's vaccine chief after a tumultuous period filled with clashes with biotech leaders and patient advocates. Citing a desire for family time, his resignation comes amid growing concerns over his management of gene therapy approvals. Dr. George Tidmarsh will take over as acting director of CBER.

1 of 1

Story summary

Dr. Vinay Prasad has stepped down as the FDA's vaccine chief after a tumultuous period filled with clashes with biotech leaders and patient advocates. Citing a desire for family time, his resignation comes amid growing concerns over his management of gene therapy approvals. Dr. George Tidmarsh will take over as acting director of CBER.